Skip to content
Methodology
All entries for: Camurus AB
September 8, 2025
Camurus AB
Orphan Drug Designation
FDA orphan drug designation: treatment of autosomal dominant polycystic kidney disease
Disease Area:
Rare Diseases
Source
Scroll to Top
